Home › Rhabdomyosarcoma › Washington
Rhabdomyosarcoma clinical trials in Washington
3 studies for Rhabdomyosarcoma are looking for participants at sites in Washington.
Cities in Washington
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Seattle Children's Hospital, Seattle
- Mary Bridge Children's Hospital and Health Center, Tacoma
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT07466316VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- Seattle Children's, Seattle
RecruitingPhase 1/2
6 Months – 30 Years · All sexes · Updated Jun 2, 2026 · NCT04796012Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
- Seattle Children's Hospital, Seattle
RecruitingPhase 1
Ages 1 to 26 · All sexes · Updated Feb 17, 2026 · NCT07148050From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.